IR Contact 2cureX

Ole Thastrup, CSO 2cureX

The principle task of 2cureX´s Investor Relations is to provide investors and the capital market with accurate, relevant and timely information that facilitates an understanding of the operations of 2cureX.100

Contact Investor Relations for details:
Ole Thastrup, CSO 2cureX
Email: IR@2cureX.com
Telephone: +45 52115399

Kenneth Graabek Johansen, CFO 2cureX
Email: IR@2cureX.com
Telephone: +45 23490227

You are also welcome to ask your question or make your request by sending us an email.
Email: info@2cureX.com

Upcoming events

October 21, 2021

Presentation by Henrik Harling (CMO 2cureX) at the 17. National Congress of Digestive Cancers (Viseu, Portugal)

Read more

November 15, 2021

Presentation by Ole Thastrup (CSO 2cureX) at the TechConnect Europe Innovation Conference & Expo (Malmø, Sweden)

Read more

November 25, 2021

Q3 2021 Interim Report released

View previous reports

February 24, 2022

Year-End Report 2021

View previous reports

IndiTreat® supports genomic characterization of tumors with unique functional information of treatment resistance and sensitivity.